3 Questions: Mriganka Sur on the research origins of the first approved drug to treat Rett syndrome
MIT Professor Mriganka Sur discusses Trofinetide, the first drug approved by the FDA to treat Rett syndrome, and his lab's original 2009 research showing that the protein IGF-1 could treat the neurological and developmental disorder.
Source: mit.edu
